Haleon plc

NYSE:HLN

Drug Manufacturers - Specialty & Generic

Healthcare
$9.08 +0.96%

+$0.08 today

Market cap
$39.85B
Beta
0.25
P/E (TTM)
29.2
EPS (TTM)
$0.11
Dividend yield
2.13%
52W Low $8.65High $11.28

Volume 19.46M

Average 8.79M

HLN Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

Haleon plcNYSE: HLN

Income Tax Expense · Q4 FY2025 · quarter ended Dec 2025

Income tax expense grows 8.1% year over year

Q4 FY2025 income tax expense of £208.71M rose 8.1% year over year. Over 3 fiscal years it compounded at -2.6% a year.

Context

  • Income tax expense amounted to 4.2% of revenue in FY2025, up 0.3 pp from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterDec 2025
£208.71M— QoQ
Last fiscal yearDec 2025
£461.66M+6.1% YoY
LTMJun 2025
£713M— YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+8.1%——
1 year+6.1%——
3-year CAGR-2.6%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

GBP · from the income statement

Latest · FY2025
461.66M GBP
Year-over-year change
+6.1%
4-year CAGR
+23.7%

Income Tax Expense vs competitors

How HLN compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Income tax expense amounts to 4.3% of revenue for HLN, versus a peer median of 3.4%.
HLN Competitors
Income Tax Expense for HLN and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CLColgate-Palmolive CompanyLTM Sep 2026$794M USD-11.9%+4.8%3.7%
HLNHaleon plcLTM Jun 2025£713M GBP—-2.6%4.3%
GSKGSK plcLTM Jun 2026£641M GBP+0.5%+16.3%1.9%
KVUEKenvue Inc.LTM Sep 2026$616M USD+27.0%-2.6%4.0%
CHDChurch & Dwight Co., Inc.LTM Sep 2026$213.7M USD-10.7%+26.2%3.4%
PRGOPerrigo Company plcLTM Jun 2026$90.7M USD-44.3%—2.2%
Peer median (excluding HLN) —-10.7%+10.6%3.4%

Competitors are the stored peer set for HLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

GBP
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue9.55B10.86B11.3B11.23B11.03B
Cost of Revenue3.6B4.28B4.34B4.29B3.83B
Gross Profit5.95B6.58B6.96B6.95B6.99B
Gross Margin62.3%60.6%61.6%61.9%63.3%
Research & Development257M300M311M298M308.1M
Selling, General & Admin3.79B4.04B4.29B4.33B4.36B
Operating Expenses4.31B4.75B4.97B4.74B4.43B
Depreciation & Amortization268M287M309M196M352.11M
EBITDA2.21B2.18B2.35B2.51B2.88B
EBITDA Margin23.2%20.1%20.8%22.4%26.1%
Operating Income1.64B1.83B2B2.21B2.41B
Operating Margin17.2%16.8%17.7%19.6%21.9%
Interest Income13M68.98M14M55M76.29M
Interest Expense16M347.36M414M394M332.55M
Other Income / Expenses(2M)(207M)(368M)(296M)(260M)
Income Before Tax1.64B1.62B1.63B1.91B2.15B
Pre-Tax Margin17.1%14.9%14.4%17.0%19.5%
Income Tax Expense197M499M517M435M461.66M
Net Income1.39B1.06B1.05B1.44B1.63B
Net Margin14.6%9.8%9.3%12.8%14.8%
EPS (Basic)0.300.240.240.320.36
EPS (Diluted)0.300.240.240.320.36
Weighted Avg Shares4.62B4.62B4.63B4.57B4.48B
Weighted Avg Shares (Diluted)4.62B4.62B4.63B4.59B4.51B

Haleon plc

NYSE:HLN

Intrinsic Alpha fair value

Locked

Current Price

$9.08

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.